Publicação

Ambliopia

Ver documento

Detalhes bibliográficos
Resumo:Amblyopia has a prevalence between 1.6% and 3.6% in countries where health care is good. These numbers are higher in countries where eye care is less effective than in wealth societies. Staying updated with the latest developments in amblyopia is fundamental for the every day practice of any eye care practitioner because amblyopia is mostly treatable when detected in time. Amblyopia is curable and that makes appropriated management, referral and prevention critical steps to avoid permanent visual consequences. The biggest challenge in amblyopia is the age of the patient, infants and children do not complain about poor vision and, most of the time, do not participate in the visual exam. This talk will touch the most crucial aspects of amblyopia, namely: classification, diagnosis, treatment, prognosis, prevention and the latest clinical and basic research findings. In addition, the latest guidelines for prescribing glasses to infants and children will be reviewed. At the end of this talk it is expected that attendees will be able to: distinguish between different types of amblyopia, indentify the patient at risk, participate in programs that aim to prevent amblyopia and make the best decisions regarding glasses prescription.
Autores principais:Macedo, António Filipe
Outros Autores:Cardoso, Ana Maria Veloso
Assunto:Ambliopia
Ano:2012
País:Portugal
Tipo de documento:outro
Tipo de acesso:acesso aberto
Instituição associada:Universidade do Minho
Idioma:português
Origem:RepositóriUM - Universidade do Minho
_version_ 1866875626212818944
author Macedo, António Filipe
author2 Cardoso, Ana Maria Veloso
author2_role author
author_facet Macedo, António Filipe
Cardoso, Ana Maria Veloso
author_role author
contributor_name_str_mv Universidade do Minho
country_str PT
creators_json_txt [{\"Person.name\":\"Macedo, António Filipe\"},{\"Person.name\":\"Cardoso, Ana Maria Veloso\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Universidade do Minho
datacite.creators.creator.creatorName.fl_str_mv Macedo, António Filipe
Cardoso, Ana Maria Veloso
datacite.date.Accepted.fl_str_mv 2012-09-01T00:00:00Z
datacite.date.available.fl_str_mv 2016-06-14T14:07:16Z
datacite.date.embargoed.fl_str_mv 2016-06-14T14:07:16Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Ambliopia
datacite.titles.title.fl_str_mv Ambliopia
dc.contributor.none.fl_str_mv Universidade do Minho
dc.creator.none.fl_str_mv Macedo, António Filipe
Cardoso, Ana Maria Veloso
dc.date.Accepted.fl_str_mv 2012-09-01T00:00:00Z
dc.date.available.fl_str_mv 2016-06-14T14:07:16Z
dc.date.embargoed.fl_str_mv 2016-06-14T14:07:16Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv https://hdl.handle.net/1822/41976
dc.language.none.fl_str_mv por
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Ambliopia
dc.title.fl_str_mv Ambliopia
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_1843
description Amblyopia has a prevalence between 1.6% and 3.6% in countries where health care is good. These numbers are higher in countries where eye care is less effective than in wealth societies. Staying updated with the latest developments in amblyopia is fundamental for the every day practice of any eye care practitioner because amblyopia is mostly treatable when detected in time. Amblyopia is curable and that makes appropriated management, referral and prevention critical steps to avoid permanent visual consequences. The biggest challenge in amblyopia is the age of the patient, infants and children do not complain about poor vision and, most of the time, do not participate in the visual exam. This talk will touch the most crucial aspects of amblyopia, namely: classification, diagnosis, treatment, prognosis, prevention and the latest clinical and basic research findings. In addition, the latest guidelines for prescribing glasses to infants and children will be reviewed. At the end of this talk it is expected that attendees will be able to: distinguish between different types of amblyopia, indentify the patient at risk, participate in programs that aim to prevent amblyopia and make the best decisions regarding glasses prescription.
dirty 0
eu_rights_str_mv openAccess
format other
fulltext.url.fl_str_mv https://prod-dspace.uminho.pt/bitstreams/b0a6156d-5940-4aa7-ac9a-4ef58b27d230/download
id rum_ff5ffefa14f32a0b0cc64e4b98656d89
identifier.url.fl_str_mv https://hdl.handle.net/1822/41976
instacron_str repositorium
institution Universidade do Minho
instname_str Universidade do Minho
language por
network_acronym_str rum
network_name_str RepositóriUM - Universidade do Minho
oai_identifier_str oai:repositorium.uminho.pt:1822/41976
organization_str_mv urn:organizationAcronym:repositorium
person_str_mv Macedo, António Filipe
Cardoso, Ana Maria Veloso
publishDate 2012
reponame_str RepositóriUM - Universidade do Minho
repository_id_str urn:repositoryAcronym:rum
service_str_mv urn:repositoryAcronym:rum
spelling porporAmblyopia has a prevalence between 1.6% and 3.6% in countries where health care is good. These numbers are higher in countries where eye care is less effective than in wealth societies. Staying updated with the latest developments in amblyopia is fundamental for the every day practice of any eye care practitioner because amblyopia is mostly treatable when detected in time. Amblyopia is curable and that makes appropriated management, referral and prevention critical steps to avoid permanent visual consequences. The biggest challenge in amblyopia is the age of the patient, infants and children do not complain about poor vision and, most of the time, do not participate in the visual exam. This talk will touch the most crucial aspects of amblyopia, namely: classification, diagnosis, treatment, prognosis, prevention and the latest clinical and basic research findings. In addition, the latest guidelines for prescribing glasses to infants and children will be reviewed. At the end of this talk it is expected that attendees will be able to: distinguish between different types of amblyopia, indentify the patient at risk, participate in programs that aim to prevent amblyopia and make the best decisions regarding glasses prescription.application/pdfporAmbliopiaMacedo, António FilipeCardoso, Ana Maria VelosoHostingInstitutionOrganizationalUniversidade do Minhoe-mailmailto:repositorium@usdb.uminho.ptrepositorium@usdb.uminho.pt2016-06-14T14:07:16Z2012-092012-09-01T00:00:00ZHandlehttps://hdl.handle.net/1822/41976http://purl.org/coar/access_right/c_abf2open accessAmbliopia408120 bytesother research producthttp://purl.org/coar/resource_type/c_1843otherhttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://prod-dspace.uminho.pt/bitstreams/b0a6156d-5940-4aa7-ac9a-4ef58b27d230/download
spellingShingle Ambliopia
Macedo, António Filipe
Ambliopia
status SINGLETON
subject.fl_str_mv Ambliopia
title Ambliopia
title_full Ambliopia
title_fullStr Ambliopia
title_full_unstemmed Ambliopia
title_short Ambliopia
title_sort Ambliopia
topic Ambliopia
topic_facet Ambliopia
url https://hdl.handle.net/1822/41976
visible 1